City

Guangzhou (1)

Milwaukee (1)

Condition

Acute Lymphoblastic Leukemia Not Having Achieved Remission (3)

Acute Lymphoblastic Leukemia, in Relapse (3)

Acute Lymphoblastic Leukemia With Failed Remission (2)

Acute Lymphoblastic Leukemia, Adult (2)

Acute Lymphoblastic Leukemia, Pediatric (2)

Acute Lymphoblastic Leukemia (1)

Acute Lymphoblastic Leukemia Recurrent (1)

Overall Status

Not yet recruiting (1)

Recruiting (1)

Unknown status (1)

Phase

phase 1 (1)

phase 2 (1)

Sponsor

Medical College of Wisconsin (1)

Nanfang Hospital of Southern Medical University (1)

University College, London (1)

Collaborator

Children's Hospital and Health System Foundation, Wisconsin (1)

Intervention

car-20/19-t cells (1)

car-20/19-t cells (1 x 10^5 car-20/19-t cells/kg) (1)

car-20/19-t cells (2.5 x10^5 car-20/19-t cells/kg) (1)

car-20/19-t cells (2.5 x10^6 car-20/19-t cells/kg) (1)

car-20/19-t cells (7.5 x10^5 car-20/19-t cells/kg) (1)

cd19-car-t2 cells (1)

Study Documents

Intervention Type

biological (2)

Funder Type

Other (3)

Study Type

Interventional (2)

Observational (1)

acute lymphoblastic leukemia not having achieved remission

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Determining the Mechanisms of Loss of CAR T Cell Persistence

Not yet recruiting

Acute Lymphoblastic Leukemia With Failed Remission
+4 more

(no location specified)

Mar 29, 2023

Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia With Failed Remission, Acute Lymphoblastic Leukemia

Recruiting

Acute Lymphoblastic Leukemia, in Relapse
+5 more

CAR-20/19-T cells (1 x 10^5 CAR-20/19-T cells/kg)
+4 more

Milwaukee, Wisconsin

Medical College of Wisconsin

Sep 22, 2022

Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia Not Having Achieved Remission, Acute Lymphoblastic

Unknown status

Acute Lymphoblastic Leukemia, in Relapse
+2 more

CD19-CAR-T2 Cells

Guangzhou, Guangdong, China

Nanfang Hospital, Southern Medical University

Oct 25, 2020